chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia
Clinical narrative: had more weakness; This spontaneous case was reported by an other caregiver and describes the occurrence of ASTHENIA (had more weakness) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Heart valve disorders and Defibrillator/pacemaker insertion.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (had more weakness). At the time of the report, ASTHENIA (had more weakness) outcome was unknown. Not Provided          No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-075153 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075153:dose 1
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Cheilitis, Chills, Injection site erythema, Injection site reaction, Malaise
Clinical narrative: feel sores under my lip; area had spread to the size of a soft ball; hot and red area at injection site started to disipate; Didn't feel well; injfection site hot spot; injection site red spot; chills; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Didn't feel well), VACCINATION SITE WARMTH (injfection site hot spot), CHEILITIS (feel sores under my lip), INJECTION SITE REACTION (hot and red area at injection site started to disipate) and RASH (area had spread to the size of a soft ball) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced MALAISE (Didn't feel well), VACCINATION SITE WARMTH (injfection site hot spot), INJECTION SITE ERYTHEMA (injection site red spot), CHILLS (chills) and PYREXIA (slight fever). On 12-Apr-2021, the patient experienced INJECTION SITE REACTION (hot and red area at injection site started to disipate). On 13-Apr-2021, the patient experienced CHEILITIS (feel sores under my lip) and RASH (area had spread to the size of a soft ball). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and LORATADINE at an unspecified dose and frequency. On 12-Apr-2021, CHILLS (chills) and PYREXIA (slight fever) had resolved. At the time of the report, MALAISE (Didn't feel well) and INJECTION SITE REACTION (hot and red area at injection site started to disipate) outcome was unknown and VACCINATION SITE WARMTH (injfection site hot spot), CHEILITIS (feel sores under my lip), RASH (area had spread to the size of a soft ball) and INJECTION SITE ERYTHEMA (injection site red spot) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided by the reporter.  Treatment medication included cold water and non itching stuff on it.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Vaccination site warmth
Clinical narrative: feel sores under my lip; area had spread to the size of a soft ball; hot and red area at injection site started to disipate; Didn't feel well; injfection site hot spot; injection site red spot; chills; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Didn't feel well), VACCINATION SITE WARMTH (injfection site hot spot), CHEILITIS (feel sores under my lip), INJECTION SITE REACTION (hot and red area at injection site started to disipate) and RASH (area had spread to the size of a soft ball) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced MALAISE (Didn't feel well), VACCINATION SITE WARMTH (injfection site hot spot), INJECTION SITE ERYTHEMA (injection site red spot), CHILLS (chills) and PYREXIA (slight fever). On 12-Apr-2021, the patient experienced INJECTION SITE REACTION (hot and red area at injection site started to disipate). On 13-Apr-2021, the patient experienced CHEILITIS (feel sores under my lip) and RASH (area had spread to the size of a soft ball). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and LORATADINE at an unspecified dose and frequency. On 12-Apr-2021, CHILLS (chills) and PYREXIA (slight fever) had resolved. At the time of the report, MALAISE (Didn't feel well) and INJECTION SITE REACTION (hot and red area at injection site started to disipate) outcome was unknown and VACCINATION SITE WARMTH (injfection site hot spot), CHEILITIS (feel sores under my lip), RASH (area had spread to the size of a soft ball) and INJECTION SITE ERYTHEMA (injection site red spot) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided by the reporter.  Treatment medication included cold water and non itching stuff on it.
Sex: M
Vaccine: COVID19
Symptoms: Cyanopsia, Magnetic resonance imaging, Ultrasound scan, Vision blurred
Clinical narrative: mesh like vision; Blue chicken wires vision; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VISION BLURRED (mesh like vision) and CYANOPSIA (Blue chicken wires vision) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included Macular degeneration. Concomitant products included OMEPRAZOLE, VITAMINS NOS and CYANOCOBALAMIN (COBALAMIN) for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jan-2021, the patient experienced VISION BLURRED (mesh like vision) and CYANOPSIA (Blue chicken wires vision). At the time of the report, VISION BLURRED (mesh like vision) outcome was unknown and CYANOPSIA (Blue chicken wires vision) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Magnetic resonance imaging: normal (normal) normal. In January 2021, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included Eye drops for macular degeneration and dry eyes. Treatment medication was not provided by the reporter.   This case was linked to MOD-2021-074784 (E2B Linked Report).; Sender's Comments:  MOD-2021-074784:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Computerised tomogram, Dyspnoea, Electrocardiogram
Clinical narrative: arms and legs got weak; breathing problems got worse; wheezing; arm swollen, knot present; felt tired; red around injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHENIA (arms and legs got weak), DYSPNEA (breathing problems got worse), WHEEZING (wheezing), PERIPHERAL SWELLING (arm swollen, knot present) and FATIGUE (felt tired) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Abnormal breathing (Patient had breathing problems.).    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced ASTHENIA (arms and legs got weak), DYSPNEA (breathing problems got worse), WHEEZING (wheezing), PERIPHERAL SWELLING (arm swollen, knot present), FATIGUE (felt tired) and VACCINATION SITE ERYTHEMA (red around injection site). At the time of the report, ASTHENIA (arms and legs got weak), DYSPNEA (breathing problems got worse), WHEEZING (wheezing), PERIPHERAL SWELLING (arm swollen, knot present), FATIGUE (felt tired) and VACCINATION SITE ERYTHEMA (red around injection site) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Apr-2021, COVID-19: other (Negative) negative. On 11-Apr-2021, Computerised tomogram: other (Negative) negative. On 11-Apr-2021, Electrocardiogram: other (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Concomitant medication was not provided by the reporter.  Treatment medication was not provided by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Peripheral swelling, Vaccination site erythema, Wheezing
Clinical narrative: arms and legs got weak; breathing problems got worse; wheezing; arm swollen, knot present; felt tired; red around injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHENIA (arms and legs got weak), DYSPNEA (breathing problems got worse), WHEEZING (wheezing), PERIPHERAL SWELLING (arm swollen, knot present) and FATIGUE (felt tired) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Abnormal breathing (Patient had breathing problems.).    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced ASTHENIA (arms and legs got weak), DYSPNEA (breathing problems got worse), WHEEZING (wheezing), PERIPHERAL SWELLING (arm swollen, knot present), FATIGUE (felt tired) and VACCINATION SITE ERYTHEMA (red around injection site). At the time of the report, ASTHENIA (arms and legs got weak), DYSPNEA (breathing problems got worse), WHEEZING (wheezing), PERIPHERAL SWELLING (arm swollen, knot present), FATIGUE (felt tired) and VACCINATION SITE ERYTHEMA (red around injection site) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Apr-2021, COVID-19: other (Negative) negative. On 11-Apr-2021, Computerised tomogram: other (Negative) negative. On 11-Apr-2021, Electrocardiogram: other (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Concomitant medication was not provided by the reporter.  Treatment medication was not provided by the reporter.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Cardiac discomfort, Cough, Dyspnoea, Fatigue
Clinical narrative: His throat briefly tightened.; vision was blurry (in and out); broke out in sweats in his: hands, neck, and underarms; His fingertips were tingling; breathing heavily; May not get second dose (unsure); his stomach cramped up; symptoms sounded like he was going into cardiac arrest; still has the hacking he had before but it is almost gone; felt very fatigue; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (His throat briefly tightened.), VISION BLURRED (vision was blurry (in and out)), HYPERHIDROSIS (broke out in sweats in his: hands, neck, and underarms), PARAESTHESIA (His fingertips were tingling) and DYSPNOEA (breathing heavily) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided.  The patient's past medical history included Common cold (Had severe hacking a week prior to the shot.) and Nose bleed (a week prior to the shot.). Concurrent medical conditions included Rhinorrhea (Had a week prior to the shot.) and Atrial fibrillation (Baseline of Atrial Fibrillation). Concomitant products included METOPROLOL, LISINOPRIL, PANTOPRAZOLE, TAMSULOSIN, PARACETAMOL (TYLENOL) and DIAZEPAM (VALIUM) for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced THROAT TIGHTNESS (His throat briefly tightened.), VISION BLURRED (vision was blurry (in and out)), HYPERHIDROSIS (broke out in sweats in his: hands, neck, and underarms), PARAESTHESIA (His fingertips were tingling), DYSPNOEA (breathing heavily), PRODUCT DOSE OMISSION ISSUE (May not get second dose (unsure)), ABDOMINAL PAIN UPPER (his stomach cramped up), CARDIAC DISCOMFORT (symptoms sounded like he was going into cardiac arrest), COUGH (still has the hacking he had before but it is almost gone) and FATIGUE (felt very fatigue). On 01-Apr-2021, PRODUCT DOSE OMISSION ISSUE (May not get second dose (unsure)) had resolved. On 02-Apr-2021, THROAT TIGHTNESS (His throat briefly tightened.), VISION BLURRED (vision was blurry (in and out)), HYPERHIDROSIS (broke out in sweats in his: hands, neck, and underarms), PARAESTHESIA (His fingertips were tingling), DYSPNOEA (breathing heavily), ABDOMINAL PAIN UPPER (his stomach cramped up), CARDIAC DISCOMFORT (symptoms sounded like he was going into cardiac arrest) and FATIGUE (felt very fatigue) had resolved. At the time of the report, COUGH (still has the hacking he had before but it is almost gone) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-075244 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075244:cluster case for several patients
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Paraesthesia, Product dose omission issue, Throat tightness, Vision blurred
Clinical narrative: His throat briefly tightened.; vision was blurry (in and out); broke out in sweats in his: hands, neck, and underarms; His fingertips were tingling; breathing heavily; May not get second dose (unsure); his stomach cramped up; symptoms sounded like he was going into cardiac arrest; still has the hacking he had before but it is almost gone; felt very fatigue; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (His throat briefly tightened.), VISION BLURRED (vision was blurry (in and out)), HYPERHIDROSIS (broke out in sweats in his: hands, neck, and underarms), PARAESTHESIA (His fingertips were tingling) and DYSPNOEA (breathing heavily) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided.  The patient's past medical history included Common cold (Had severe hacking a week prior to the shot.) and Nose bleed (a week prior to the shot.). Concurrent medical conditions included Rhinorrhea (Had a week prior to the shot.) and Atrial fibrillation (Baseline of Atrial Fibrillation). Concomitant products included METOPROLOL, LISINOPRIL, PANTOPRAZOLE, TAMSULOSIN, PARACETAMOL (TYLENOL) and DIAZEPAM (VALIUM) for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced THROAT TIGHTNESS (His throat briefly tightened.), VISION BLURRED (vision was blurry (in and out)), HYPERHIDROSIS (broke out in sweats in his: hands, neck, and underarms), PARAESTHESIA (His fingertips were tingling), DYSPNOEA (breathing heavily), PRODUCT DOSE OMISSION ISSUE (May not get second dose (unsure)), ABDOMINAL PAIN UPPER (his stomach cramped up), CARDIAC DISCOMFORT (symptoms sounded like he was going into cardiac arrest), COUGH (still has the hacking he had before but it is almost gone) and FATIGUE (felt very fatigue). On 01-Apr-2021, PRODUCT DOSE OMISSION ISSUE (May not get second dose (unsure)) had resolved. On 02-Apr-2021, THROAT TIGHTNESS (His throat briefly tightened.), VISION BLURRED (vision was blurry (in and out)), HYPERHIDROSIS (broke out in sweats in his: hands, neck, and underarms), PARAESTHESIA (His fingertips were tingling), DYSPNOEA (breathing heavily), ABDOMINAL PAIN UPPER (his stomach cramped up), CARDIAC DISCOMFORT (symptoms sounded like he was going into cardiac arrest) and FATIGUE (felt very fatigue) had resolved. At the time of the report, COUGH (still has the hacking he had before but it is almost gone) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-075244 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075244:cluster case for several patients
Sex: U
Vaccine: COVID19
Symptoms: Contusion
Clinical narrative: Bruise on foot due to fall of shampoo bottle; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CONTUSION (Bruise on foot due to fall of shampoo bottle) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported. ). Concomitant products included RIVAROXABAN (XARELTO) for Atrial flutter.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced CONTUSION (Bruise on foot due to fall of shampoo bottle). At the time of the report, CONTUSION (Bruise on foot due to fall of shampoo bottle) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-074278 (E2B Linked Report).; Sender's Comments:  MOD21-074278:MOD-2021-075192 - 2nd dose of vaccine
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: under age patient received dose; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under age patient received dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under age patient received dose). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under age patient received dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Dry mouth
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of DRY MOUTH (dryness of the mouth) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DRY MOUTH (dryness of the mouth). At the time of the report, DRY MOUTH (dryness of the mouth) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment medication was reported.
Sex: U
Vaccine: COVID19
Symptoms: Discomfort, Insomnia, Pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of insomnia (sleeplessness), discomfort and pain in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. March 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. March 2021, patient experienced insomnia (sleeplessness), discomfort and pain. At the time of the report, insomnia (sleeplessness), discomfort and pain resolved. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown. No concomitant medication or treatment medication provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: chills; fever; nausea; lot of dizziness; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lot of dizziness), FATIGUE (fatigue), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT), LANSOPRAZOLE (PREVACID), ATORVASTATIN, LISINOPRIL, PRAMIPEXOLE DIHYDROCHLORIDE (MIRAPEX), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), ASCORBIC ACID (C VITAMIN), MAGNESIUM, ZINC, FISH OIL and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (fatigue). On 08-Apr-2021, the patient experienced HEADACHE (headache). On 12-Apr-2021, the patient experienced DIZZINESS (lot of dizziness). On 13-Apr-2021, the patient experienced CHILLS (chills), PYREXIA (fever) and NAUSEA (nausea). On 08-Apr-2021, FATIGUE (fatigue) and HEADACHE (headache) had resolved. At the time of the report, DIZZINESS (lot of dizziness), CHILLS (chills), PYREXIA (fever) and NAUSEA (nausea) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not provided by the reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: chills; fever; nausea; lot of dizziness; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lot of dizziness), FATIGUE (fatigue), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT), LANSOPRAZOLE (PREVACID), ATORVASTATIN, LISINOPRIL, PRAMIPEXOLE DIHYDROCHLORIDE (MIRAPEX), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), ASCORBIC ACID (C VITAMIN), MAGNESIUM, ZINC, FISH OIL and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (fatigue). On 08-Apr-2021, the patient experienced HEADACHE (headache). On 12-Apr-2021, the patient experienced DIZZINESS (lot of dizziness). On 13-Apr-2021, the patient experienced CHILLS (chills), PYREXIA (fever) and NAUSEA (nausea). On 08-Apr-2021, FATIGUE (fatigue) and HEADACHE (headache) had resolved. At the time of the report, DIZZINESS (lot of dizziness), CHILLS (chills), PYREXIA (fever) and NAUSEA (nausea) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not provided by the reporter.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cough, Headache, Myalgia, Pyrexia
Clinical narrative: felt "run down" for 2 days; cough; fever; headache; muscles ache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (felt "run down" for 2 days), COUGH (cough), PYREXIA (fever), HEADACHE (headache) and MYALGIA (muscles ache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced ASTHENIA (felt "run down" for 2 days), COUGH (cough), PYREXIA (fever), HEADACHE (headache) and MYALGIA (muscles ache). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. On 19-Mar-2021, ASTHENIA (felt "run down" for 2 days), COUGH (cough), PYREXIA (fever), HEADACHE (headache) and MYALGIA (muscles ache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 13-Apr-2021 and was forwarded to the company on 13-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included IBUPROFEN, CITALOPRAM, VERAPAMIL and PRAVASTATIN for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced NAUSEA (Nausea). On 24-Mar-2021, NAUSEA (Nausea) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   This case was linked to MOD21-074326 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD21-074326:
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Muscular weakness, Pain in extremity
Clinical narrative: muscle weakness; Painful Legs; can't walk; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 13-Apr-2021. The most recent information was received on 04-Aug-2021 and was forwarded to Moderna on 05-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Painful Legs), GAIT DISTURBANCE (can't walk) and MUSCULAR WEAKNESS (muscle weakness) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (Painful Legs) and GAIT DISTURBANCE (can't walk). On an unknown date, the patient experienced MUSCULAR WEAKNESS (muscle weakness). The patient was treated with TRAMADOL for Pain in extremity, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Painful Legs), GAIT DISTURBANCE (can't walk) and MUSCULAR WEAKNESS (muscle weakness) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Significant follow up received; Contact information updated, new event added and event outcome also updated
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Muscular weakness, Myalgia
Clinical narrative: Diarrhea; Muscle weakness over back of both thighs and buttocks; Vomiting; Fatigue; Muscle ache; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), MUSCULAR WEAKNESS (Muscle weakness over back of both thighs and buttocks), VOMITING (Vomiting), FATIGUE (Fatigue) and MYALGIA (Muscle ache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), MUSCULAR WEAKNESS (Muscle weakness over back of both thighs and buttocks), VOMITING (Vomiting), FATIGUE (Fatigue), MYALGIA (Muscle ache) and HEADACHE (Headache). On 16-Mar-2021, DIARRHOEA (Diarrhea) and VOMITING (Vomiting) had resolved. On 19-Mar-2021, FATIGUE (Fatigue), MYALGIA (Muscle ache) and HEADACHE (Headache) had resolved. At the time of the report, MUSCULAR WEAKNESS (Muscle weakness over back of both thighs and buttocks) had not resolved.            No concomitant medications were reported No treatment was taken when received second dose of vaccine. The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up received on 05-Aug-2021 and included no new information.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Diarrhea; Muscle weakness over back of both thighs and buttocks; Vomiting; Fatigue; Muscle ache; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), MUSCULAR WEAKNESS (Muscle weakness over back of both thighs and buttocks), VOMITING (Vomiting), FATIGUE (Fatigue) and MYALGIA (Muscle ache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), MUSCULAR WEAKNESS (Muscle weakness over back of both thighs and buttocks), VOMITING (Vomiting), FATIGUE (Fatigue), MYALGIA (Muscle ache) and HEADACHE (Headache). On 16-Mar-2021, DIARRHOEA (Diarrhea) and VOMITING (Vomiting) had resolved. On 19-Mar-2021, FATIGUE (Fatigue), MYALGIA (Muscle ache) and HEADACHE (Headache) had resolved. At the time of the report, MUSCULAR WEAKNESS (Muscle weakness over back of both thighs and buttocks) had not resolved.            No concomitant medications were reported No treatment was taken when received second dose of vaccine. The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up received on 05-Aug-2021 and included no new information.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Pain
Clinical narrative: Still in pain; side effects getting worse; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Still in pain) and CONDITION AGGRAVATED (side effects getting worse) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 002A21A) for COVID-19 vaccination.     The patient's past medical history included Fibromyalgia (At the time, MRI studies and nerve conduction studies were done.) in 2017 and Heart attack in 2019. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) and METOPROLOL for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PAIN (Still in pain) and CONDITION AGGRAVATED (side effects getting worse). At the time of the report, PAIN (Still in pain) and CONDITION AGGRAVATED (side effects getting worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-075127 (E2B Linked Report). This case was linked to MOD-2021-031481 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: VAERS; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075127:MOD-2021-075127 (Case for dose1)
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia, Vomiting
Clinical narrative: Fever of 103; Vomiting; Body aches; Real bad chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Real bad chills), PYREXIA (Fever of 103), VOMITING (Vomiting) and MYALGIA (Body aches) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 003B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced CHILLS (Real bad chills). On 21-Mar-2021, the patient experienced PYREXIA (Fever of 103), VOMITING (Vomiting) and MYALGIA (Body aches). On 21-Mar-2021, CHILLS (Real bad chills), PYREXIA (Fever of 103), VOMITING (Vomiting) and MYALGIA (Body aches) had resolved.            No relevant concomitant medications were provided.  No treatment information was provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: sick for 2 & 1/2 days after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick for 2 & 1/2 days after receiving the vaccine) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced ILLNESS (sick for 2 & 1/2 days after receiving the vaccine). At the time of the report, ILLNESS (sick for 2 & 1/2 days after receiving the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed Second Dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed Second Dose) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed Second Dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed Second Dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided. No treatment medications were reported.  Reportedly, the patient was in his 20s and received the first dose in Jan-2021 and didn't receive the second dose. No other information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Painful aches and pains; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Painful aches and pains) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN (Painful aches and pains). At the time of the report, PAIN (Painful aches and pains) outcome was unknown. Not Provided          The patient's medical history was not provided.  No relevant concomitant medications were reported. The patient did not receive any treatment. The patient received both scheduled doses of mRNA-1273 prior to the events, therefore, the action taken with the drug in response to the events was not applicable. Reporter did not allow further contact.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Feeling abnormal, Headache, Myalgia, Neck pain
Clinical narrative: woke up and was not good; Neck, arm and body hurt completely; Headache; Neck, arm and body hurt completely; bit of sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (bit of sore arm), FEELING ABNORMAL (woke up and was not good), NECK PAIN (Neck, arm and body hurt completely), HEADACHE (Headache) and MYALGIA (Neck, arm and body hurt completely) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032321A) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol since 2006. Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (bit of sore arm). On 13-Apr-2021, the patient experienced FEELING ABNORMAL (woke up and was not good), NECK PAIN (Neck, arm and body hurt completely), HEADACHE (Headache) and MYALGIA (Neck, arm and body hurt completely). The patient was treated with CORTISONE at a dose of 1 shot. At the time of the report, PAIN IN EXTREMITY (bit of sore arm), FEELING ABNORMAL (woke up and was not good), NECK PAIN (Neck, arm and body hurt completely), HEADACHE (Headache) and MYALGIA (Neck, arm and body hurt completely) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Body temperature: 101.5 (High) 101.5°F.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       This case was linked to MOD-2021-271732 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Significant FU -Batch number, medical history, concomitant and treatment medications added.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: woke up and was not good; Neck, arm and body hurt completely; Headache; Neck, arm and body hurt completely; bit of sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (bit of sore arm), FEELING ABNORMAL (woke up and was not good), NECK PAIN (Neck, arm and body hurt completely), HEADACHE (Headache) and MYALGIA (Neck, arm and body hurt completely) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032321A) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol since 2006. Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (bit of sore arm). On 13-Apr-2021, the patient experienced FEELING ABNORMAL (woke up and was not good), NECK PAIN (Neck, arm and body hurt completely), HEADACHE (Headache) and MYALGIA (Neck, arm and body hurt completely). The patient was treated with CORTISONE at a dose of 1 shot. At the time of the report, PAIN IN EXTREMITY (bit of sore arm), FEELING ABNORMAL (woke up and was not good), NECK PAIN (Neck, arm and body hurt completely), HEADACHE (Headache) and MYALGIA (Neck, arm and body hurt completely) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Body temperature: 101.5 (High) 101.5°F.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       This case was linked to MOD-2021-271732 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Significant FU -Batch number, medical history, concomitant and treatment medications added.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site was tender to touch; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site was tender to touch) and VACCINATION SITE PAIN (Sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection site was tender to touch) and VACCINATION SITE PAIN (Sore arm). On 20-Mar-2021, VACCINATION SITE PAIN (Injection site was tender to touch) and VACCINATION SITE PAIN (Sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient usually takes a cocktail / glass of wine at night and also takes medical cannabis , especially CBD and some THC, at every night. Patient wants to know regarding whether alcohol, cannabis, NSAID or Tylenol will affect the immune response, either before or after his second shot.   Patient is scheduled for his second shot on 14Apr2021. Concomitant medications and treatment information was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Neck pain, Pain in jaw
Clinical narrative: Back of neck painful; Right jaw painful; Sense of smell heightened, repulsed at certain smells; Felt achy all over; Head hurt all over; Very very tired/ Suddenly will feel fatigued at times; Developed fever of 102 F; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Back of neck painful), PAIN IN JAW (Right jaw painful), PAROSMIA (Sense of smell heightened, repulsed at certain smells), PYREXIA (Developed fever of 102 F) and MYALGIA (Felt achy all over) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Allergy to antibiotic (erythromycin), Drug allergy (sulfa), Drug allergy (Toprol) and Blood pressure high.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced PYREXIA (Developed fever of 102 F). On 07-Apr-2021, the patient experienced NECK PAIN (Back of neck painful), PAIN IN JAW (Right jaw painful), PAROSMIA (Sense of smell heightened, repulsed at certain smells), MYALGIA (Felt achy all over), HEADACHE (Head hurt all over) and FATIGUE (Very very tired/ Suddenly will feel fatigued at times). On 06-Apr-2021, PYREXIA (Developed fever of 102 F) had resolved. On 08-Apr-2021, NECK PAIN (Back of neck painful), PAIN IN JAW (Right jaw painful), PAROSMIA (Sense of smell heightened, repulsed at certain smells), MYALGIA (Felt achy all over) and HEADACHE (Head hurt all over) had resolved. At the time of the report, FATIGUE (Very very tired/ Suddenly will feel fatigued at times) outcome was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Parosmia, Pyrexia
Clinical narrative: Back of neck painful; Right jaw painful; Sense of smell heightened, repulsed at certain smells; Felt achy all over; Head hurt all over; Very very tired/ Suddenly will feel fatigued at times; Developed fever of 102 F; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Back of neck painful), PAIN IN JAW (Right jaw painful), PAROSMIA (Sense of smell heightened, repulsed at certain smells), PYREXIA (Developed fever of 102 F) and MYALGIA (Felt achy all over) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Allergy to antibiotic (erythromycin), Drug allergy (sulfa), Drug allergy (Toprol) and Blood pressure high.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced PYREXIA (Developed fever of 102 F). On 07-Apr-2021, the patient experienced NECK PAIN (Back of neck painful), PAIN IN JAW (Right jaw painful), PAROSMIA (Sense of smell heightened, repulsed at certain smells), MYALGIA (Felt achy all over), HEADACHE (Head hurt all over) and FATIGUE (Very very tired/ Suddenly will feel fatigued at times). On 06-Apr-2021, PYREXIA (Developed fever of 102 F) had resolved. On 08-Apr-2021, NECK PAIN (Back of neck painful), PAIN IN JAW (Right jaw painful), PAROSMIA (Sense of smell heightened, repulsed at certain smells), MYALGIA (Felt achy all over) and HEADACHE (Head hurt all over) had resolved. At the time of the report, FATIGUE (Very very tired/ Suddenly will feel fatigued at times) outcome was unknown.